Rochester, NY 8/21/2009 1:12:37 AM
Anika Therapeutics, Inc. ANIK, Anika Therapeutics Increase by 18% in Net Income for the Second Quarter
Anika Therapeutics, Inc.
Anika Therapeutics recently posted a net income of $956,000, or $0.08 per diluted share, for the second quarter ended June 30, 2009, an 18% increase, compared to $813,000, or $0.07 per diluted share, during the same period of last year.
For the second quarter of 2009, total revenues were $9.52 million, compared to $9.06 million in the second quarter of 2008.
For the first six months ended June 30, 2009, net income increased 3% to $1.48 million, or $0.13 per diluted share, from $1.43 million, or $0.12 per diluted share, for the first six months of 2008. Total revenues were $18.72 million, compared to $17.61 million in the first six months of 2008.
About Stock EinsteinStockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
